As the digital world continues to evolve, it's no surprise that today’s healthcare providers are more digitally savvy than ever. However, the analog methods used by pharma for HCP engagement, proved to be a hurdle that needed overcoming...
The pandemic expedited a change to the status quo and
DISCREEDLY will be a key partner for this transformational shift!
HCP engagement platform
Streamlined Access To Medical Affairs
seamless connection to enable needs-based scientific exchange
centralized data dissemination and tailored content delivery
Transform Your Medical Affairs Team
With Next-Gen Engagement Tools!
Discreedly is a digital platform that will be available via both a web based application and also a mobile app. The platform will provide pharma companies with a resource for omnichannel engagement with HCPs as well as provide various reports and analytics to optimize engagement strategies.
Discreedly provides HCPs with access to information and resources (like on-demand MSLs), to receive the information they need and prescribe the right medication for their patients. Discreedly also allows HCPs to receive real-time updates on their frequently prescribed medications, to stay current on the newest data and improve their patient outcomes.
Co-Founder & CEO
Vinay is a physician by training and prior to founding Discreedly, he has spent the last 8 years of his career in the medical affairs space of the pharmaceutical industry.
Co-Founder & COO
Gibu is also a physician by training and prior to co-founding Discreedly, he has spent the last 7 years of his career in the medical informatics space of the healthcare industry.
“MD's want more personalized engagement and tailored content. They increasingly expect pharma to demonstrate an understanding of their needs and interests”